NASDAQ: AMSS
AMASS BRANDSCIK 0001851491 · SIC 2080 · Beverages
Micro by assets
Assets $28M
as of Sep 27, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (IPW 10-K) is open in full — no account needed.
424B5
Filed Aug 24, 2026
Summary not yet generated.
424B5
Filed Aug 24, 2026
Amass Brands registers resale of 8.95M shares by existing stockholders; company gets no proceeds
3 material changes detected. Sign up free to read the summary.
Partner
Trade AMSS commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Aug 21, 2026
· Period ending Aug 19, 2026
Summary not yet generated.
8-K
Filed Aug 17, 2026
· Period ending Aug 17, 2026
Summary not yet generated.
10-Q
Filed Aug 14, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
8-K
Filed Aug 5, 2026
· Period ending Jul 29, 2026
Summary not yet generated.
8-K
Filed Jul 31, 2026
· Period ending Jul 29, 2026
Summary not yet generated.
8-K
Filed Jul 27, 2026
· Period ending Jul 22, 2026
Summary not yet generated.
424B5
Filed Jul 10, 2026
Summary not yet generated.
8-K
Filed Jul 10, 2026
· Period ending Jul 10, 2026
Summary not yet generated.
424B3
Filed Jul 6, 2026
Summary not yet generated.
8-K
Filed Jun 30, 2026
· Period ending Jun 25, 2026
AMASS increases AfterDream SAFE investment by $200K to $1.74M at unchanged $7.5M cap
1 material change detected. Sign up free to read the summary.
S-1
Filed Jun 30, 2026
Summary not yet generated.
10-Q
Filed Jun 29, 2026
· Period ending Mar 31, 2026
Summary not yet generated.
8-K
Filed Jun 23, 2026
· Period ending Jun 16, 2026
Summary not yet generated.
8-K
Filed Jun 15, 2026
· Period ending Jun 12, 2026
Summary not yet generated.
424B5
Filed Jun 15, 2026
Summary not yet generated.
8-K
Filed May 29, 2026
· Period ending May 29, 2026
Summary not yet generated.
424B5
Filed May 29, 2026
Summary not yet generated.
424B4
Filed May 18, 2026
Summary not yet generated.
S-1/A
Filed May 4, 2026
Summary not yet generated.
S-1/A
Filed Apr 30, 2026
Summary not yet generated.
S-1/A
Filed Apr 23, 2026
Summary not yet generated.
S-1
Filed Apr 9, 2026
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 14, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Net revenues | ||||
| Spirits & wine revenues | 5,404,448 | 5,455,110 | 9,390,882 | 9,614,886 |
| Other revenues | 188,296 | 49,722 | 351,205 | 230,489 |
| Total net revenues | 5,592,744 | 5,504,832 | 9,742,087 | 9,845,375 |
| Cost of net revenues | ||||
| Cost of spirits & wine revenues | 3,558,488 | 3,344,070 | 6,367,880 | 6,130,937 |
| Cost of other revenues | 538,707 | 16,209 | 805,716 | 355,126 |
| Total cost of net revenues | 4,097,195 | 3,360,279 | 7,173,596 | 6,486,063 |
| Gross profit | 1,495,549 | 2,144,553 | 2,568,491 | 3,359,312 |
| Operating expenses | ||||
| Sales and marketing | 1,059,877 | 976,375 | 2,027,354 | 1,969,780 |
| General and administrative | 6,054,188 | 1,917,192 | 8,570,993 | 4,035,292 |
| Impairment loss | 339,283 | - | 449,685 | - |
| Total operating expenses | 7,453,348 | 2,893,567 | 11,048,032 | 6,005,072 |
| Loss from operations | (5,957,799) | (749,014) | (8,479,541) | (2,645,760) |
| Other income (expense) | ||||
| Interest income | - | 27,752 | 3,709 | 34,235 |
| Interest expense | (1,337,046) | (491,992) | (1,791,902) | (2,036,252) |
| Change in fair value of derivative liabilities | 236,969 | - | 187,753 | - |
| Change in fair value of SAFEs | (10,635) | - | (21,062) | - |
| Other income (expense), net | (480,704) | (52,169) | (489,779) | (337,267) |
| Total other income (expense) | (1,591,416) | (516,409) | (2,111,281) | (2,339,284) |
| Net loss | (7,549,215) | (1,265,423) | (10,590,822) | (4,985,044) |
| Net loss attributable to non controlling interest | (74,938) | (28,840) | (80,841) | (91,419) |
| Net loss attributable to parent | (7,474,277) | (1,236,583) | (10,509,981) | (4,893,625) |
| Foreign currency translation adjustment | - | - | - | - |
| Total comprehensive loss | (7,474,277) | (1,236,583) | (10,509,981) | (4,893,625) |
| Weighted average common shares outstanding basic and diluted | 10,764,492 | 3,115,656 | 7,139,009 | 3,073,828 |
| Net loss per common share basic and diluted | (0.69) | (0.40) | (1.47) | (1.59) |
Consolidated Balance Sheets (Unaudited)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Assets | ||
| Current Assets | ||
| Cash and cash equivalents | 1,570,517 | 824,962 |
| Accounts receivable, net | 4,043,745 | 2,317,514 |
| Due from related parties | - | 1,389,996 |
| Inventory, net | 11,208,045 | 10,873,408 |
| Interest receivable | 68,112 | 68,112 |
| Prepaid expenses and other current assets | 883,809 | 178,205 |
| Total current assets | 17,774,228 | 15,652,197 |
| Property and equipment, net | 5,044 | 12,369 |
| Intangible assets, net | 1,829,895 | 2,202,579 |
| Goodwill | 2,972,280 | 2,972,280 |
| Securities pledged as collateral, at fair value | - | 3,347,564 |
| Investments at fair value | 3,347,564 | - |
| Investments at cost | 406,000 | 823,746 |
| Related-party investment | 1,888,331 | - |
| Deposits | 16,640 | 14,015 |
| Total assets | 28,239,982 | 25,024,750 |
| Liabilities and stockholders' equity ( deficit ) | ||
| Current liabilities | ||
| Accounts payable | 9,619,480 | 8,257,052 |
| Accrued expenses | 4,480,307 | 4,306,428 |
| Secured credit facility, current | 3,788,522 | 3,277,034 |
| Loans payable, current | 1,166,998 | 897,854 |
| Contract liabilities | 2,933,102 | 3,042,044 |
| Promissory notes payable, current | 1,650,000 | 2,498,714 |
| Derivative liabilities | 883,167 | 37,962 |
| Customer deposits | 413,838 | 417,000 |
| Interest payable | 421,213 | 694,649 |
| Obligation under repurchase agreement | - | 400,000 |
| Total current liabilities | 25,356,627 | 23,828,737 |
| Loans payable | 164,570 | 831,568 |
| Promissory notes payable, net | - | 100,000 |
| Convertible notes payable | - | 378,725 |
| SAFE notes | 541,304 | 520,242 |
| Total liabilities | 26,062,501 | 25,659,272 |
| Commitments and contingencies (Note 15) | ||
| Series C Convertible Preferred Stock, $0.00001 par, 7,000 shares issued and outstanding, liquidation value of $7,608,720 plus accrued and unpaid preferred return, at carrying value (mezzanine equity) | 1,184,077 | - |
| Stockholders' equity ( deficit ) : | ||
| Series B Preferred Stock, $0.00001 par; 0 and 8,304,185 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | - | 82 |
| Series A Preferred Stock, $0.00001 par; 0 and 873,734 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | - | 9 |
| Series Seed Preferred Stock, $0.00001 par; 0 and 12,529,020 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | - | 125 |
| Common stock, $0.00001 par, 250,000,000 shares authorized; 11,760,456 shares issued and 11,605,081 shares outstanding as of June 30, 2026, and 3,364,984 shares issued and outstanding as of December 31, 2025 | 118 | 34 |
| Additional paid-in capital | 51,273,945 | 37,661,354 |
| Treasury stock, 155,375 and 0 shares at cost | (1,393,713) | - |
| Accumulated other comprehensive income | 55,172 | 55,172 |
| Accumulated deficit | (51,215,008) | (40,705,027) |
| Total Amass stockholders’ deficit | (1,279,486) | (2,988,251) |
| Non-controlling interest | 2,272,890 | 2,353,729 |
| Total stockholders’ equity (deficit) | 993,404 | (634,522) |
| Total liabilities and stockholders' equity (deficit) | 28,239,982 | 25,024,750 |
Consolidated Statements of Cash Flows (Unaudited)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| Net loss | (10,590,822) | (4,985,044) |
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation and amortization | 269,607 | 335,137 |
| Stock-based compensation | 447,545 | 221,464 |
| Issuance of common stock shares for services | 2,631,799 | - |
| Amortization of debt discounts | 1,207,730 | 321,941 |
| Warrant modifications of the terminated inducement offering charged to operations | 514,313 | - |
| Reserve for expected credit losses | 17,864 | (10,298) |
| Impairment of intangible assets and investments | 449,685 | - |
| Change in fair value of derivative liabilities | (187,753) | - |
| Change in fair value of SAFE | 21,062 | - |
| Inventory obsolescence | 246,385 | 8,885 |
| Loss on sale of securities at fair value | - | 280,143 |
| Changes in operating assets and liabilities | ||
| Accounts receivable | (1,744,094) | (825,207) |
| Inventory, net | (581,023) | 2,907,233 |
| Prepaid expenses and other current assets | (297,200) | 11,733 |
| Accounts payable | 1,359,803 | (654,654) |
| Accrued expenses | 173,882 | (728,991) |
| Interest receivable | - | (25,887) |
| Interest payable | 41,768 | 1,799,123 |
| Customer deposits | (3,162) | - |
| Contract liabilities | (108,942) | (2,122) |
| Net cash used in operating activities | (6,131,553) | (1,346,544) |
| Cash flows from investing activities | ||
| Advances to related parties | (3,717) | (87,686) |
| Sale of investment | - | 500,000 |
| Proceeds from notes receivable | - | 346,663 |
| Purchase of related-party investment | (1,786,593) | - |
| Purchases of property and equipment, net of disposals | - | 11,610 |
| Purchases / disposals of intangible assets, net | - | (17,470) |
| Net cash (used in) provided by investing activities | (1,790,310) | 753,117 |
| Cash flows from financing activities | ||
| Proceeds from (repayments of) secured credit facility, net | 511,488 | (125,854) |
| R epayments of loans payable, net | (197,854) | (137,959) |
| Proceeds from issuance of promissory notes | - | 945,000 |
| Proceeds from convertible notes, net | 1,351,675 | - |
| Proceeds from issuance of Series C Convertible Preferred Stock | 7,000,000 | - |
| Proceeds from issuance of Common Stock | - | 470,759 |
| Offering costs | (452,512) | (396,755) |
| Proceeds from exercise of stock options | 4,184 | 375 |
| Proceeds from exercise of warrants | 850,437 | 51,406 |
| Obligation under repurchase agreement | (400,000) | - |
| Net cash provided by financing activities | 8,667,418 | 806,972 |
| Net change in cash and cash equivalents | 745,555 | 213,545 |
| Cash and cash equivalents, beginning of the period | 824,962 | 693,946 |
| Cash and cash equivalents, end of the period | 1,570,517 | 907,491 |
| Supplemental Disclosure of Cash Flow Information | ||
| Cash paid for income taxes | 9,373 | 13,833 |
| Cash paid for interest | 340,352 | 516,353 |
| Noncash Investing and Financing Activities | ||
| Transfer of investment for relief of debt | - | 1,000,000 |
| Warrants issued with promissory notes | - | 615,427 |
| Exchange of shareholder promissory note for convertible note | 1,000,000 | - |
| Conversion of Convertible Notes and accrued interest into Common Stock | 3,791,850 | - |
| Common Stock issued as Series C commitment fee shares | 450,000 | - |
| Incremental fair value of Warrant modifications capitalized to deferred offering costs | 431,680 | - |
| Derivative recognized with Series C financing | 849,236 | - |
| Warrants issued with Series C Preferred Stock | 4,824,382 | - |
| Shares issued in extinguishment of accrued interest | 276,475 | - |
| Reclassification of securities pledged as collateral to investments at fair value upon De Soi collateral release | 3,347,564 | - |
| Issuance of SAFE for reduction of promissory note principal | - | 500,000 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗